Presentation is loading. Please wait.

Presentation is loading. Please wait.

Half life- 1 The half-life OCT 2010. Half life- 2 The plasma half-life Synonymous half-life of elimination half-life of the terminal phase.

Similar presentations


Presentation on theme: "Half life- 1 The half-life OCT 2010. Half life- 2 The plasma half-life Synonymous half-life of elimination half-life of the terminal phase."— Presentation transcript:

1 Half life- 1 The half-life OCT 2010

2 Half life- 2 The plasma half-life Synonymous half-life of elimination half-life of the terminal phase

3 Half life- 3 The half-life Half-life has the apparent advantage of being a familiar term

4 Half life- 4 The half-life Definition Time required to divide the plasma concentration by two after reaching pseudo-equilibrium distribution Not the time necessary for the amount of administered drug in the body to fall by one-half !

5 Half life- 5 The half-life Meaning in terms of drug elimination (half-life vs mean residence time (MRT)) Concentration MRT = 16 h MRT = 4 h t1/2 = 12 h 24 time (h)

6 Half life- 6 Meaning in terms of drug elimination t1/2 = time to eliminate half the dose t1/2 = time to eliminate half the remaining dose monocompartmental model The half-life

7 Half life- 7 Pharmacokinetic meaning of half-life

8 Half life- 8 Half-life vs. Clearance Clearance : ability to eliminate Half-life : overall elimination during the terminal phase which depends on both clearance and distribution

9 Half life- 9 Clearance vs. half-life Amiodarone Clearance: 1.9 ml/kg/min Half-life: 25 days Amikacine Clearance: 1.3 ml/kg/min Half-life: 2.3 hours

10 Half life- 10 The half-life Meaning in terms of elimination and distribution

11 Half life- 11 The half-life is a hybrid parameter Distribution large small Clearance high low Half-life equal

12 Half life- 12 Plasma clearance vs plasma half-life

13 Half life- 13 Half-life (HL), Clearance (Cl) & volume of distribution (Vd) of Amiodarone vs. amikacin DrugsHL (h) Cl ml/kg/min Vd L/kg amiodarone amikacin

14 Half life- 14 The half-life is a hybrid parameter t 1/2 = function of K 10, K 12 and K 21 t 1/2 K 12 K 21 K 10

15 Half life- 15 t 1/ 2 = /2 ( k 12 + k 21 + k 10 ) - ( k 12 + k 21 + k 10 ) k 21 k 10 k 10 k 12 k 21 Hybrid parameter t 1/ 2 = The half-life

16 Half life- 16 t 1/ 2 = x Volume of distribution Clearance Half-life is a hybrid parameter reflecting both clearance and volume of distribution

17 Half life- 17 If half-life increases it is because Volume of distribution  or Clearance 

18 Half life- 18 Volume of Distribution Volume of Distribution Terminal half-life is a hybrid parameter : Clint Vmax Km P t Ka fu p Clearance t 1/2 ° Q fu B V B V t fu b fu T fu p : fraction of the total number of sites of free fixation Ka : affinity constant Km : Michaelis constant The half-life

19 Half life- 19 In pharmacokinetics, all the time parameters are hybrid parameters Time parameters

20 Half life- 20 k 10 k 12 k 21 k 12 = distribution clearance / Vc k 10 = plasma clearance / Vc k 21 = redistribution clearance / Vp t 1/2 vie = V area / plasma clearance MRT : Vss / plasma clearance Vc Vp Hybrid parameters Hybrid properties of time parameters

21 Half life- 21 Consequences of the hybrid properties of time parameters Interpretation of rate constant

22 Half life- 22 Interpretation of K 10 k 10 = Cl / Vc dependent variable 2 independent variables Wrong interpretation of clearance Cl = K 10 x Vc (computation technique) ! Interpretation of rate constant

23 Half life- 23 The half-life Consequence of its hybrid property a poor parameter to evaluate the influence of a pathology (e.g.: renal failure) in drug disposition dosage adaptation should be based on clearance not half-life

24 Half life- 24 Why calculate a half-life ? Dosage regimen Dose Clearance Interval of administration Half-life

25 Half life- 25 Half-life Systemic exposure Clearance Volume of distribution bioavailability Dosing regimen How often? Dosage regimen How much Absorption

26 Half life- 26 Half-life defines the dosing interval If half-life is short requires dosage form with a low input rate Problem in maintaining steady-state drug concentration

27 Half life- 27 Half-life defines the dosage interval If half-life is long drug accumulation long delay to reach steady state conditions requires a loading dose

28 Half life- 28 In case of multiple administration : to predict drug accumulation to predict time of steady state Why calculate a half-life?

29 Half life- 29 Why calculate a half-life ? To predict drug accumulation To predict the time of steady-state To determine the dosage interval Essential to develop a new drug with respect to compliance (eg: antibiotic)

30 Half life x  Why calculate a half-life ? To predict drug accumulation R = 1 1- e t 1/2 Accumulation index Half-lifeInterval of administration R= AUCss AUC1 AUCss Mono-compartmental model or if drug is administered in the post distribution phase for a x-compartmental model

31 Half life- 31 Why calculate a half-life To predict the time of steady state it is independent of the dosing interval it is only a function of the terminal half-life (3-4 times)

32 Half life- 32 Why calculate a half-life Delay to reach steady state conditions if a drug is administered daily, the steady state will be reached after the 2nd or 3rd administration for all the drugs having a terminal half-life < 12 h

33 Half life- 33 Half-life and delay to reach steady state conditions Monocompartmental 50% = half-life 90% = 3.3 half-life

34 Half life- 34 Hypothetical drug: half-life : 24h dosage interval :  = 24h maintenance dose = 50 R = = = 2 Half-life, accumulation and steady-state concentration 1 1- e /24h * 24h

35 Half life- 35 DaysJust after dosing24h later infinity10050 Half-life, accumulation and steady-state concentration Ratio = 2

36 Half life- 36 Hypothetical drug: half-life : 24h dosage interval :  = 12h maintenance dose = 25 R = = 3.41 Half-life, accumulation and steady-state concentration 1 1- e /24h * 12h

37 Half life- 37 DaysHoursJust after dosing12h later infinity Half-life, accumulation and steady-state concentration Ratio= 3.42

38 Half life- 38 Half-life Bicompartmental model

39 Half life- 39 Bicompartmental Function of elimination fraction during initial and terminal phase t 1/2 2 control drug accumulation if at least 50% of the drug is eliminated during the terminal phase Half-life accumulation and delay to reach steady state conditions

40 Half life- 40 Half-life and delay to reach steady state conditions Bicompartmental model : plasma concentrations Apparent steady state is more rapidly reached when most of the drug is eliminated during the distribution phase t 1/2 2 control drug accumulation if at least 50% of the drug is eliminated during the terminal phase t1/2 = 5h t1/2 = 48h t1/2 = 5h t1/2 = 48h day R = +++ R = +

41 Half life- 41 Half-life and delay to reach steady state conditions Peripheral compartment delay to reach steady state conditions in the deepest tissular compartment is always controlled by t1/2 z (residues,doping). a "pseudo-plateau" can be reached earlier in plasma and shallow tissues than in deep tissues compartment rate of accumulation is associated with Kz1 and Kz1 is a major determinant of z

42 Half life- 42 Half-life and delay to reach steady state conditions Plasma vs shallow and deep compartment shallow (2) 1 deep (3) Time Amount

43 Half life- 43 Aim : to immediately reach the steady state conditions (Css) LD = Vss x Css Loading dose (LD)

44 Half life- 44 Loading dose (LD) (first dose=LD) LD = maintenance dose 1- e - x  or LD = maintenance dose x accumulation index LD for the first example =50x2=100 LD for the second example=25X3.42=85.5

45 Half life- 45 Technical considerations for the calculation of half-life

46 Half life- 46 Estimation Linear regression Peeling method (residuals) Non-linear regression Half-life

47 Half life- 47 z Yz How to calculate it t 1/2 = / z a semilogarithmic plot representation Half-life

48 Half life- 48 Weighing factor and terminal half-life

49 Half life- 49 Rate constant K el = = Fractional rate of drug elimination can be viewed as the fraction of the volume of distribution from which drug is removed by unit of time e.g.: K el = 0.01 h -1  1% per h Rate of elimination Amount in body Cl V

50 Half life- 50 Sampling conditions for the appropriate estimation of t 1/2 At least 3 times the expected t 1/2 if 24 hours = sampling are over at least 3 days

51 Half life- 51 Half-life and sampling times Time (hours) Concentrations t 1/2 =20 hours t 1/2 = 28 hours t 1/2 = 48.7 hours +20%  = +20% -20%

52 Half life- 52 Half-life and level of quantification (LOQ)

53 Half life- 53 (ng/ml) Time (days) 5 h days days 100 half-life AUC(%) C(t) = 100 e t + 10 e t + 1 e t Half-life and the level of quantification (LOQ) of the analytical technique

54 Half life- 54 Terminal half-life of gentamicin 44h 129h 154h 142h 87h 53h The very long terminal HL of gentamicin is due to its slow release from tissues and account for urinary excretion for 3 weeks after a dose in man and long withdrawal times in food producing animals

55 Half life- 55 Variability of half-life Generally an analytical artefact Concentration time (h) LOQ

56 Half life- 56 C(t) = 100 e t + 10 e t + 1 e t Time (h), Dose = 100 LOQ (ng/ml) Clearance Vss MRT (day) Varea (L) t1/2 (h) /0.66 1/ /6.7 1/6.6 1/10 Ratio Bias in the estimation of PK parameters with respect to the LOQ

57 Half life- 57 Where to stop ? (1) Answer : calculate the AUC associated with each phase Y(t) = Y 1 exp(- 1 t) + Y 2 exp(- 2 t) AUC 1 = Y 1 / 1 AUC 2 = Y 2 / 2 Y1Y1 Y2Y2 1 2 Half-life and the LOQ of the analytical technique

58 Half life- 58 Where to stop ? (2) Examples : Y(t) = 1000 exp(-1t) exp(-0.1t) + 1exp(-0.01t) AUC = (16.4%) (82%) (1.6%) Y(t) = 1000exp(-1t) + 500exp(-0.1t) + 100exp(-0.01t) AUC = (6.8%) (31.3%) (62.5%) Half-life and the LOQ of the analytical technique

59 Half life- 59 Where to stop ? (3) example of gentamicin phase 1 : t1/2 = 5 min phase 2 : t1/2 2 = 2 h phase 3 : t1/2 3 = 24 h AUC phase 1 and 2 = 98% Conclusion : 98% of gentamicin has already been eliminated when the equilibrium of pseudo-distribution occurs Half-life and the LOQ of the analytical technique

60 Half life- 60 Le cas des « Very late terminal phases » LOQ Benchmark concentration

61 Half life- 61 The half-time for extravascular route of administration

62 Half life IM IV Plasma Concentration (ng / ml) Pred. sodium succinatePred. acetate Hours Toutain et al. Am.J.Vet.Res 1985, 46: Prednisolone (0.6mg/kg) IM HL=3.7h HL=48h

63 Half life- 63 Half -absorption or half-elimination ? a rate-limited absorption (flip-flop) must be recognized EV: rate of elimination EV: rate of absorption time (C) IV What is the meaning of the terminal half-life after an extravascular drug administration?

64 Half life- 64 (ng/ml) Terminal half-life and the flip-flop case F% =  100% Ka1 Ka1 + Ka2 K a1 K a2 negligible K 12 K 21 K 10 Time Ka=K a1 +K a2 # K a1 = flip-flop Slow process of absorption elimination

65 Half life- 65 Flip-flop: a pictural view Baignoire avec réserve d’eau (dose), un robinet (ka) et une bonde (K 10, clairance) (Ka) (K 10 )

66 Half life- 66 (Ka) (K 10 ) Flip-flop: a pictural view

67 Half life- 67 To measure the absorption rate using some special methods IM route k a1 k a2 k 10 k a k 10 k a1 k 10 k a2 k 12 k 21 k a   ? ? What is the meaning of the terminal half-life after an extravascular drug administration?

68 Half life- 68 Half-life: summary Definition Interpretation elimination distribution Usefulness single dose multiple dose

69 Half life- 69 Drug elimination expressed in terms of amount in the body dA/dt = -  A or = = Rate of elimination Amount in the body Elimination rate constant is regarded as the fractional rate of drug removal - dA/dt A


Download ppt "Half life- 1 The half-life OCT 2010. Half life- 2 The plasma half-life Synonymous half-life of elimination half-life of the terminal phase."

Similar presentations


Ads by Google